From Bioactive Pyrrolidino[3,4-c]pyrrolidines to more Bioactive Pyrrolidino[3,4-b]pyrrolidines via Ring-Opening/Ring-Closing Promoted by Sodium Methoxide

^¥ Corresponding Author for Calculations: [e-mail]

Abstract

The process involving a rearrangement of pyrrolidino[3,4-c]pyrrolidine to another pyrrolidino[3,4-b]pyrrolidine using sodium methoxide as base is fully studied. The effects of the substituents are analyzed during the ring-opening/ring-closing sequence. Computational studies are also performed to explain the importance of susbstituents and quaternary carbons, especially when the (3-indolyl)methyl is present in the starting material. Finally, all the samples are evaluated as potential candidates for antibacterial and antimycobacterial activities.

Key words

cycloaddition - azomethine ylides - rearrangement - antibacterials - DFT calculations

• References

• 1 Patil MM, Rajput SS. Int. J. Pharm. Pharm. Sci. 2014; 6: 8
• 2 Kumar S, Prakash S, Gupta K, Dongre A, Balaram P, Balaram H. Nat. Commun. 2016; 7: 1

For other applications of maleimides, see:
• 3a Miller CW, Jönsson ES, Hoyle CE, Viswanathan K, Valente EJ. J. Phys. Chem. B 2001; 105: 2707
• 3b Dolci E, Froidevaux V, Joly-Duhamel C, Auvergne R, Boutevin B, Caillol S. Polymers 2016; 56, 512
• 4 Wang L, Ni Q, Blümel M, Shu T, Raabe G, Enders D. Chem. Eur. J. 2015; 21: 1
• 5a Dondas HA, Retamosa M. deG, Sansano JM. Synthesis 2017; 49: 2819
• 5b Wróbel MZ, Chodkowski A, Herold F, Gomólka A, Kleps J, Mazurek AP, Plucinski F, Mazurek A, Nowak G, Siwek A, Stachowicz K, Slawinska A, Wolak M, Szewczyk B, Satala G, Bojarski AJ, Turlo J. Eur. J. Med. Chem. 2013; 63: 484
• 5c Gupta P, Garg P, Roy N. Med. Chem. Res. 2010; 22: 5014
• 5d Nájera C, Sansano JM. Curr. Top. Med. Chem. 2014; 14: 1105
• 5e Nájera C, Sansano JM. Org. Biomol. Chem. 2009; 7: 4567
• 6 Nural Y, Döndas HA, Grigg R, Sahin E. Heterocycles 2011; 83: 2091

For previous contributions from our group in the study of pharmaceutical properties of new compounds, see:
• 7a Poyraz S, Belveren S, Ulger M, Sahin E, Dondas HA. Monatsh. Chem. 2017; 148: 2173
• 7b Poyraz, S.; Canacankatan, N.; Belveren, S.; Yetkin D.; Kibar, K.; Ülger, M.; Sansano, J. M.; Özcelik, N. D.; Yilmaz, S. N.; Döndaş, H. A. Monatsh. Chem. 2018, 149, 2253.
• 8 Belveren S, Döndas HA, Ülger M, Poyraz S, García-Mingüens E, Ferrandiz-Saperas M, Sansano JM. Tetrahedron 2017; 73: 6718
• 9a Wellington K, Plosker GL. Drugs 2002; 62: 1539
• 9b Zhang MZ, Chen Q, Yang GF. Eur. J. Med. Chem. 2015; 89: 421
• 9c Sherer C, Snape TJ. Eur. J. Med. Chem. 2015; 97: 552
• 9d Zhang MZ, Mulholland N, Beattie D, Irwin D, Gu YC, Chen Q, Yang GF, Clough J. Eur. J. Med. Chem. 2013; 63: 22
• 9e Leneva IA, Russel RJ, Boriskin YS, Ha AJ. Antiviral Res. 2009; 81: 132
• 9f Kaushik NK, Kaushik N, Attri P, Kumar N, Kim CH, Verma AK, Choi EH. Molecules 2013; 18: 6620
• 9g Welsch ME, Syner SA, Stockwell BR. Curr. Opin. Chem. Biol. 2010; 14: 347
• 10 Compound 5ga was obtained previously by our group in 85% yield, see ref. 6.
• 11 CCDC 1534206 for compound 7gg contains the supplementary crystallographic data for this paper. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.

β-​Proline derivatives exhibit anticancer or antibacterial activities:
• 12a Kudryavtsev KV. Yu. C.-C, Ivantcova PM, Polshakov VI, Churakov AV, Braese S, Zefirov NS, Guh JH. Chem. Asian J. 2015; 10: 383
• 12b Ferrazzano L, Viola A, Lonati E, Bulbarelli A, Musumeci R, Cocuzza C, Lombardo M, Tolomelli A. Eur. J. Med. Chem. 2016; 124: 906
• 12c Fjelbye K, Marigo M, Clausen RP, Juhl K, Karsten J. Synlett 2017; 28: 231
• 13 CCDC 1533867 for compound 6gf contains the supplementary crystallographic data for this paper. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures.
• 14a Palomino JC, Portaels F. Eur. J. Clin. Microbiol. Infect. Dis. 1999; 18: 380
• 14b National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardia, and Other Aerobic Actinomycetes: Approved Standard NCCLS Document M24-a. NCCLS. 2003 (Wayne, Pennsylvania).
• 15 National Committee for Clinical Laboratory Standards. Tentativ Standard- Second Edition NCCLS Document M24-T. Susceptibilitiy Testing of Mycobacteria, Nocardia and other aerobic Actinomycetes. 2002. Pennsylvania USA).
• 16 Grigg R, Gunaratne HQ. N, Sridharan V. Tetrahedron 1987; 43: 5887
• 17 Dondas HA, Altinbas O. Heterocycl. Commun. 2004; 10: 167
• 18 Becke AD. J. Chem. Phys. 1993; 98: 5648
• 19 Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA, Peralta JE, Ogliaro F, Bearpark MJ, Heyd J, Brothers EN, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell AP, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam NJ, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas Ö, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ. Gaussian 09, Revision E.01 . Gaussian Inc; Wallingford, CT: 2013
• 20 Parr RG, Yang W. Density-Functional Theory of Atoms and Molecules . Oxford University Press; New York: 1989
• 21 Grimme S, Antony J, Ehrlich S, Krieg HJ. Chem. Phys. 2010; 132: 154104
• 22 Cammi R, Mennucci B, Tomasi J. J. Phys. Chem. A 2000; 104: 5631
• 23 Tomasi J, Mennucci B, Cammi R. Chem. Rev. 2005; 105: 2999